AgeX Therapeutics Inc (AGE): Cell Senescence, Telomerase, and Senolyt...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	23
Posts	1782
Boards Moderated	0
Alias Born	12/05/2020

saxonia40271

Re: None

Sunday, 05/23/2021 5:11:00 PM

Sunday, May 23, 2021 5:11:00 PM

Cell Senescence, Telomerase, and Senolytic Therapy

http://lidsen.com/journals/geriatrics/geriatrics-03-01-034

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AGE News

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results • GlobeNewswire Inc. • 03/22/2024 09:27:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/07/2024 09:49:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:47:08 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/07/2024 12:47:43 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:01:43 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:21 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:05:20 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/05/2024 12:19:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:05:39 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/17/2024 09:19:13 PM
Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 01/16/2024 02:11:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:05:36 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/09/2024 09:16:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:05:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:02:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:25:54 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/13/2023 10:11:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:05:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:05:38 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/16/2023 09:01:20 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/15/2023 02:38:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:25:21 PM
AgeX Therapeutics Reports Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM

More AGE News

InvestorsHub NewsWire

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM

Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM

ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM

Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM

Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM

Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover